INC Research to Present at Upcoming Jefferies Global Healthcare Conference

RALEIGH, N.C., May 31, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq: INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 2017 Jefferies Global Healthcare Conference in New York, NY.  Mr. Macdonald’s presentation is scheduled for Wednesday, June 7, 2017, at 11 a.m. EDT.

Links to INC Research’s live presentation and archived audio replay, as well as the presentation materials, will be available via the Company’s Investor Relations website at investor.incresearch.com.

About INC ResearchINC Research (Nasdaq: INCR) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.  Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market.  The Company was ranked “Top CRO to Work With” among the top 10 global CROs in the 2017 CenterWatch Global Investigative Site Relationship Survey.  INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 110 countries.  For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.

Investor Relations Contact:
Ronnie Speight
Vice President, Investor Relations
Phone: +1 (919) 745-2745
Email: [email protected]

Press/Media Contact:
Lori Dorer
Senior Director, Corporate Communications
Phone: +1 (919) 745-2890
Email: [email protected]

You May Also Be Interested In

• Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases
• The 80/20 Institute Introduces an Approach to Expand Margin Without Cutting — by Concentrating on the 20% That Drives Profit
• The 80/20 Institute Releases a 100-Day Playbook for PE-Backed CEOs Under Value-Creation Pressure